Chlorotoxin-Conjugated Multifunctional Dendrimers Labeled with Radionuclide 131I for Single Photon Emission Computed Tomography Imaging and Radiotherapy of Gliomas
Chlorotoxin-Conjugated Multifunctional Dendrimers Labeled with Radionuclide 131I for Single Photon Emission Computed Tomography Imaging and Radiotherapy of Gliomas
复制标题
放射性核素 131I 标记的氯毒素偶联多功能树枝状聚合物用于神经胶质瘤的单光子发射计算机断层扫描成像和放射治疗
DOI:
10.1021/acsami.5b05836
复制
发表时间:
2015-09-09
影响因子:
9.5
通讯作者:
Zhao, Jinhua
中科院分区:
文献类型:
--
作者:
Zhao, Lingzhou;Zhu, Jingyi;Zhao, Jinhua
Chlorotoxin-conjugated multifunctional dendrimers labeled with radionuclide 'I were synthesized and utilized for targeted single photon emission computed tomography (SPECT) imaging and radiotherapy of cancer. In this study, generation five amine-terminated poly(amidoamine) dendrimers were used as a platform to be sequentially conjugated with polyethylene glycol (PEG), targeting agent chlorotoxin (CTX), and 3-(4'-hydroxyphenyl)propionic acid-OSu (HPAO). This was followed by acetylation of the remaining dendrimer terminal amines and radiolabeling with I-131 to form the targeted theranostic dendrimeric nanoplatform. We show that the dendrimer platform possessing approximately 7.7 CTX and 21.1 HPAO moieties on each dendrimer displays excellent cyto compatibility in a given concentration range (0-20 itM) and can specifically target cancer cells overexpressing matrix metallopeptidase 2 (MMP2) due to the attached CTX. With the attached HPAO moiety having the phenol group, the dendrimer platform can be effectively labeled with radioactive I-131 with good stability and high radiochemical purity. Importantly, the I-131 labeling renders the dendrimer platform with an ability to be used for targeted SPECT imaging and radiotherapy of an MMP2-overexpressing glioma model in vivo. The developed radiolabeled multifunctional dendrirneric nanoplatform may hold great promise to be used for targeted theranostics of human gliomas.